logo
Plus   Neg
Share
Email

Affimed Posting Steep Loss After Halting Studies Of Cancer Drug

After gapping open sharply lower, shares of Affimed N.V. (AFMD) continue to see substantial weakness in afternoon trading on Tuesday. Affimed is currently down by 24.3 percent after hitting its lowest intraday level in over a month.

The initial sell-off by Affimed came after the biopharmaceutical company placed two clinical trials of its cancer treatment AFM11 on hold after one patient died and two others experienced life-threatening events.

Affimed said it will be working closely with the global health authorities, the Safety Monitoring Committees, and the studies' clinical investigators to review the events, carefully assess all of the data and determine next steps for the AFM11 program.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MWE Investments is recalling dual fuel portable generators citing fire risk, according to the U.S. Consumer Product Safety Commission. The recall involves about 7,500 units of Westinghouse WGen5300DFv Dual Fuel Portable Generators and Westinghouse iGen4500DF Dual Fuel Inverter Portable Generators. According to the agency, the dual fuel portable generators can leak fuel. Apple Inc. (AAPL) will launch an online store in India on September 23, offering the tech giant's full range of products and support directly to customers across the country for the first time. U.S. retail sales continued to recover from the coronavirus pandemic in August, showing a slight improvement from July and larger gains than last year, the National Retail Federation or NRF said. However, the pace of growth slowed from July. The NRF said in a statement that August retail sales edged up 0.1 percent seasonally adjusted from July and rose 5.6 percent unadjusted year-over-year.
Follow RTT